18440512. ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES simplified abstract (Universal Display Corporation)
Contents
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
Organization Name
Inventor(s)
Hsiao-Fan Chen of Lawrence Township NJ (US)
Rasha Hamze of Philadelphia PA (US)
Morgan C. Macinnis of Yardley PA (US)
Nicholas J. Thompson of New Hope PA (US)
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES - A simplified explanation of the abstract
This abstract first appeared for US patent application 18440512 titled 'ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
Simplified Explanation: The patent application describes a compound with a specific structure outlined in Formula I.
Key Features and Innovation:
- The compound has a unique structure that is detailed in Formula I.
- The innovation lies in the specific arrangement of atoms within the compound.
- This structure offers potential benefits in various applications due to its unique properties.
Potential Applications: The compound could potentially be used in pharmaceuticals, materials science, or other industries where its specific structure could be advantageous.
Problems Solved: The technology addresses the need for compounds with a specific structure outlined in Formula I, which may have been previously unavailable.
Benefits: The compound's unique structure could lead to advancements in various fields, potentially offering new solutions and opportunities for research and development.
Commercial Applications: The compound could have commercial applications in pharmaceuticals, materials science, or other industries where its unique structure could provide a competitive advantage.
Prior Art: Readers interested in prior art related to compounds with similar structures outlined in Formula I could start by researching existing patents in the relevant fields.
Frequently Updated Research: Stay informed about any new research or developments related to compounds with structures similar to Formula I to understand the latest advancements in the field.
Questions about the Compound: 1. What are the potential implications of the compound's unique structure in pharmaceutical applications? 2. How does the compound's structure compare to existing compounds in the market?
Original Abstract Submitted
A compound having a structure of Formula I,
